Arturo Simoni 🦉
@arturo_vedder
PhD in HCC/MASLD
ID: 998407945170882561
https://www.researchgate.net/profile/Arturo-Simoni 21-05-2018 03:39:38
130 Tweet
141 Followers
768 Following
Our London Team is expanding: our new Post-Doc Arturo Simoni Nieves (Arturo Simoni 🦉) joined the Liver Metabolism and NAFLD Lab at the @Inst_of_Hep to work on Advanced Liver Cultures focussing on #NASH & NASH-HCC. Please join me & Gabriele Mocciaro in wishing him best of luck!
Is #HDL lipidome a player in #NAFLD pathophysiology? Our study led by Gabriele Mocciaro, Jules Griffin (Rowett Institute, Cambridge Biochemistry), Albert Koulman (Inst Metabolic Science-Metabolic Research Labs), us (Uniba.it Aldo Moro, @Inst_of_Hep) and Mike Allison (NIHR Cambridge Biomedical Research Centre, Addenbrooke's) et al suggests so. sciencedirect.com/science/articl…
The new global consensus nomenclature Steatotic Liver Disease is released as we speak. Remember to read the paper! The paper is now released journal-of-hepatology.eu/article/S0168-… EASLnews Jeffrey V. Lazarus Joost PH Drenth AASLD ALEH Phil Newsome Maru Rinella MD
Some bacteria produce cholesterol In your face, eukaryotes! 😆 Paula Welander Stanford Doerr School of Sustainability Stanford University nature.com/articles/s4146…
just for the pleasure of it, the fine choreography of epithelial cell migration with a PI3K mutation. This is the complex behavior we have to drug to treat cancer ... Movie from Lucien Hinderling . Switch sound on.
Researchers in Prof. Yosef Yarden's lab have developed an advanced synthetic antibody with potential as an anticancer drug. A study published in Cell Reports Medicine demonstrates that this antibody can prevent or significantly delay drug resistance in mice